1Seuano M.A new regulatory motify in cell cycle control causingspecific inhibition If cyclinD/CDK4.Nature 1993 ;366:704
2William H,et al.Role of the p16 tumor suppressor gene in cancer.Journal of Clinical Oncology 1998; 16(3):1197
3Stoot F j,et al.The alternative product from the human CDKN2A locus,p14ARF,participate in a regulatory feedback loop with p53 and MDM2.EMBO J 1998; 17:5001
4lily I,et al.p16INK4a and the control of cellular proliferative life span.Carcinogenesis 1999 ;20(6):921
5Jacobs J J L,et al.The oncogene and polycomh-group gene bmilregulates cell proliferation and senescence through the ink4a locus.Nature 1999; (397):164
6Caims P,et al.Frequency of homozygous deletion at p16/CDKN2 in primary human tumors.Nature Genet 1995; (11):210
7Herbert J,et al.Candidate tumor suppressor genes MTS l(p16INK4a)and MTS2(p15INK4a) display frequent homozygous deletion in primary cells from T-but not B-cell lineage acute lymphocytic leukemias.Blood 1994;4:4038
8Maelandsmo GM,et al.Homozygous deletion frequency and expressionn levels of the CDKN2 gene in human sarcomas-Relatiornship to amplification and mRNA levels of CDK4 and CCNDI.Br J Cancer1995;72:393
9Reed A,et al.High frequency of p16(CDKN2/MTS-1/INK4A)inactivation in head and neck squamous cell carcinoma.Cancer Res 1996; 56:3630
10Maesawa C,et al.Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is assoctated with advanced stage esophageal squamous cell carcinoma.Cancer Res 1996;56:3875
